Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Can you solve it faster than others? Billionaire Investor Bill Ackman Just Went All In On One of His Favorite Stocks: He ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

US stocks sold off sharply on Tuesday as bond yields hit a nine-month high on the back of stronger-than-expected economic ...

BMO Capital Markets boosted their price target on shares of Vertex from $42.00 to $52.00 and gave the stock a “market perform” rating in a research note on Thursday, November 7th. Morgan ...

On Friday, Raymond (NS:RYMD) James altered its view on Vertex (NASDAQ:VRTX) Inc. (NASDAQ: VERX) stock, shifting from an "Outperform" rating to a "Market Perform" status. The change comes after ...

One commentator stated on X "Vertex often gets the benefit of the doubt given its track record, but damn, this one is tough to reconcile." The company's announcements come mere days after insider ...

Vertex Pharmaceuticals (VRTX ... Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction ...